News

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The Department of Psychiatry and Behavioral Sciences ranked ninth in the country for NIH funding in 2023.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

MUSC researchers find differences in young adults’ experience of cannabis and risk for cannabis use disorder based on genetics and sex.

Patrick Flume, M.D., was recently honored with the Cystic Fibrosis Foundation's 2024 Impact Award.

Can their older son’s rare, debilitating disorder be treated? British family turns to MUSC scientist whose expertise in MEF2C looks promising.

Symposium will bring together researchers and patient advocates to inform policy and chart the way forward for patients with rare diseases.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

As FDA approves new treatments for sickle cell, patient prepares for trial testing another one. “This has been something that I've been hoping for.”